About us

Ottawa Hospital Research Institute 2013–2014 Annual Report

Overview

The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and an affiliated institute of the University of Ottawa. Our research is focused on answering important health questions and translating new findings into benefits for patients and the community. Our goal is to make tomorrow’s health care possible today; bringing new hope to our patients, while advancing health research at a global level.

With more than 1,700 scientists, clinical investigators, trainees and staff, as well as total annual revenues of approximately $100 million, the Ottawa Hospital Research Institute is one of the foremost Canadian hospital-based research institutes.

We are investigating virtually every major disease and condition. Our research spans the full spectrum of health science, from basic molecular biology and epidemiology, to clinical trials and the development of new therapies, to health services and knowledge translation research.

Our research programs

  • Cancer Therapeutics
  • Chronic Disease
  • Clinical Epidemiology
  • Neurosciences
  • Regenerative Medicine

Vision and Strategic Research

The Ottawa Hospital Research Institute vision is to give our patients and their loved ones new hope through research that is making tomorrow’s health care possible today.

This vision expresses our commitment to research that is focused on and inspired by patients. We approach our work with compassion and dedication each day, knowing that every question we answer and every problem we solve could eventually impact many people, including our own loved ones.

To support our vision, we have developed two strategic research priorities:

  1. Regenerative and biological therapeutics: Fostering bench-to-bedside research by turning basic discoveries in cellular and molecular biology into new regenerative and biological therapeutics to improve health.
  2. Practice-changing research: Putting knowledge to work by performing high-quality clinical research that can inform health decisions, and ensuring that results are optimally applied to improve health.

We have also developed a crosscutting strategic research theme on vascular health, which is designed to foster an exciting area of research that focuses on the role of blood vessels in health and disease. This theme cuts across all of our existing programs, fits well with our partners and addresses a major challenge for the health and wellbeing of Canadians.

Leadership Team

The Ottawa Hospital Research Institute is a not-for-profit corporation governed by a board of directors that includes members from the University of Ottawa, The Ottawa Hospital and the community.

Board Chair

Ian Mumford

Chief Operating Officer, Canadian Blood Services

Treasurer

Christa Casey

Welch LLP, Partner and Director of the Not-for-Profit Sector Ottawa

Board of Directors

Dr. Jacques Bradwejn

Dean, Faculty of Medicine, University of Ottawa

Ian Curry

President and CEO, DNA Genotek

Gary Hannah

President and CEO , Vocantas

Don Hewson

President and CEO, HBS Marketing

Dr. Jack Kitts

President and CEO, The Ottawa Hospital

Louis Lamontagne

Entrepreneur

Rose Lipiec Montoya

Financial Planner, TD Waterhouse Financial Planning

Randall Marusyk

Managing Partner, MBM Intellectual Property Law

Dr. Mona Nemer

Vice-President, Research, University of Ottawa

Ken Newport

Biotech entrepreneur

Hélène Perrault

Dean, Faculty of Health Sciences, University of Ottawa

Brian Radburn

CFO, Panacis

Dr. Duncan Stewart

CEO and Scientific Director, Ottawa Hospital Research Institute, Vice-President of Research, The Ottawa Hospital and Professor of Medicine, University of Ottawa

Bashir Surani

Member of The Ottawa Hospital Board of Governors

D. Lynne Watt

Partner, Gowling Lafleur Henderson LLP

Shirley Westeinde

Chair, Westeinde Group of Companies

Senior Management Team

Dr. Duncan Stewart

CEO and Scientific Director

Dr. Rashmi Kothary

Deputy Scientific Director

Dr. Jay Baltz

Associate Scientific Director, Trainees

Dr. Dean Fergusson

Program Director, Clinical Epidemiology

Dr. Antoine Hakim

Program Director, Neurosciences

Robert Hanlon

Chief Operating Officer

Dr. Michael McBurney

Program Director, Cancer Therapeutics

Dr. Leo Renaud

Associate Scientific Director

Dr. Michael Rudnicki

Program Director, Regenerative Medicine

Dr. Alexander Sorisky

Program Director, Chronic Disease

Dr. Catherine Tsilfidis

Director, Equity, Diversity and Gender Issues

Dr. Phil Wells

Associate Scientific Director, Clinical Research

Affiliated with uOttawa

Copyright 2014 Ottawa Hospital Research Institute

Back to top